Cellzome expands scientific advisory board
This article was originally published in Scrip
Executive Summary
Cellzome has appointed Professors Ruedi Aebersold, Anne Ferguson-Smith, Jeannie Lee and Diane Mathis to its scientific advisory board. Professor Aebersold co-founded the Institute of Molecular Systems Biology at the Swiss Federal Institute of Technology (ETH Zurich). Professor Ferguson-Smith is professor of developmental genetics at the University of Cambridge and Professor Lee is an investigator of the Howard Hughes Medical Institute and professor of genetics and pathology at Harvard Medical School and the Massachusetts General Hospital. Professor Mathis is a professor of pathology at Harvard Medical School, and a principal faculty member of the Harvard Stem Cell Institute and an associate member at the Broad Institute.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.